Data / Form D filings / RESQ PHARMACEUTICALS INC.
RESQ PHARMACEUTICALS INC.: Form D filings
RESQ PHARMACEUTICALS INC., a pharmaceuticals company in Henderson, NV, filed 2 Form D notices with the SEC between 2020 and 2021. The latest, on June 29, 2021, reports $8.8 million sold of a $10 million offering to 52 investors.
Find out what RESQ PHARMACEUTICALS INC. does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 3535 EXECUTIVE TERMINAL DRIVE, SUITE 110, Henderson, NV, 89052
- Phone
- (701) 541-9222
- Industry
- Pharmaceuticals
- Entity type
- Corporation
- Incorporated in
- Delaware
- Year incorporated
- 2019
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1805243
The full lists. Form D filings in Nevada: 610 rows, $30.50, or the new rows each week for $19 a month. Form D filings in Pharmaceuticals: 346 rows, $17.30, or the new rows each week for $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, street, city, state, ZIP and 4 more), which open on your screen as soon as the payment clears and come by email. For agents and scripts: every list with its row count and price is at https://specstream.ai/data/lists.json.
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Jun 29, 2021 | New notice | $10,000,000 | $8,804,985 | $1,195,015 | 52 | Jun 14, 2021 | sec.gov |
| Apr 23, 2020 | New notice | $2,000,000 | $247,000 | $1,753,000 | 2 | Apr 7, 2020 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| BEN ESQUE | Executive Officer, Director |
Every Form D from the week of Jun 28, 2021 · All recent filings in Nevada · All recent Pharmaceuticals filings
Read from SEC EDGAR. Amount sold is what RESQ PHARMACEUTICALS INC. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.
$10 of credit on sign-up, no card.